Insulin Glargine Yfgn + Octreotide Interaction
Majorinteraction on record
Description
Somatostatin analog that may increase risk of hypoglycemia. Dosage reductions and increased glucose monitoring may be required.
Source: NLP:insulin glargine-yfgn
Somatostatin analog that may increase risk of hypoglycemia. Dosage reductions and increased glucose monitoring may be required.
Source: NLP:insulin glargine-yfgn